HERTRAZ 150MG INJECTION

Content Reviewed By:

Written By:

• HER2, or human epidermal growth factor receptor 2, is a protein that, when overexpressed on the surface of certain cancer cells, fuels their uncontrolled growth. These elevated levels of HER2 act as a signal, constantly telling the cancer cells to divide and multiply rapidly. HERTRAZ 150MG INJECTION is a targeted therapy designed to specifically address this issue. It works by selectively binding to the HER2 protein on the surface of these cancer cells. This binding action effectively blocks the HER2 receptor, preventing it from sending growth signals to the cancer cell. By disrupting this signaling pathway, HERTRAZ 150MG INJECTION helps to slow down or even stop the growth and spread of cancer cells that overexpress HER2. This targeted approach minimizes damage to healthy cells, reducing overall side effects compared to traditional chemotherapy.
• By blocking HER2, HERTRAZ 150MG INJECTION deprives cancer cells of a crucial growth signal.
• This targeted action helps to slow or stop cancer growth with potentially fewer side effects.
• HERTRAZ 150MG INJECTION offers a focused treatment option for cancers that rely on HER2 for growth.

• HERTRAZ 150MG INJECTION is typically administered under the supervision of a healthcare professional, either before or after surgery, depending on the specific treatment plan. This medication is delivered intravenously, meaning it's given directly into a vein. The initial infusion usually takes around 90 minutes to allow the medical team to monitor for any potential reactions or side effects. During this first infusion, close observation is crucial to ensure the patient tolerates the medication well.
• If the initial 90-minute infusion is well-tolerated without significant adverse reactions, subsequent doses of HERTRAZ 150MG INJECTION can be administered over a shorter period, typically around 30 minutes. This expedited infusion time can make the treatment process more convenient for the patient. However, the decision to shorten the infusion duration always rests with the healthcare provider, based on their assessment of the patient's individual response and tolerance to the medication.
• It's essential to adhere to the prescribed dosage and administration schedule provided by your doctor or healthcare team. Do not attempt to self-administer this medication. If you have any concerns or experience any unusual symptoms during or after the infusion, inform your healthcare provider immediately.